Volume 23 Number 16
August 2021

Home > Publications > Neuro-Oncology Reviews > Volume 23, Year 2021 > Number 16, August

Fiani B, Covarrubias C, Onyedimma C, Jarrah R.
Neurocytological Advances in the Treatment of Glioblastoma Multiforme.
Cureus. 2021 Jul 10;13(7):e16301. doi: 10.7759/cureus.16301. PMID: 34405064. Review.

Giotta Lucifero A, Luzzi S.
Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II).
Brain Sci. 2021 Jul 23;11(8):976
. doi: 10.3390/brainsci11080976. PMID: 34439595. Review.

Ahn SS, Cha S.
Pre- and Post-Treatment Imaging of Primary Central Nervous System Tumors in the Molecular and Genetic Era.
Korean J Radiol. 2021 Jul 26. doi: 10.3348/kjr.2020.1450. Online ahead of print. PMID: 34402244. Review.

Kiesel B, Freund J, Reichert D, Wadiura L, Erkkilae MT, Woehrer A, Hervey-Jumper S, Berger MS, Widhalm G.
5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches.
Front Oncol. 2021 Jul 30;11:699301. doi: 10.3389/fonc.2021.699301. PMID: 34395266. Review.

Liang X, Wang Z, Dai Z, Zhang H, Cheng Q, Liu Z.
Promoting Prognostic Model Application: A Review Based on Gliomas.
J Oncol. 2021 Aug 3;2021:7840007. doi: 10.1155/2021/7840007. PMID: 34394352. Review.

Lahkim M, Andour H, Laamrani FZ, Nouali HE, Fenni JE.
Cystic meningioma: A case report with a literature review.
Radiol Case Rep. 2021 Aug 4;16(10):2958-2961. doi: 10.1016/j.radcr.2021.07.016. PMID: 34401033. Case report & Review.

Karachi A, Dastmalchi F, Nazarian S, Huang J, Sayour EJ, Jin L, Yang C, Mitchell DA, Rahman M.
Optimizing T Cell-Based Therapy for Glioblastoma.
Front Immunol. 2021 Aug 5;12:705580. doi: 10.3389/fimmu.2021.705580. PMID: 34421912. Review.

Najem H, Khasraw M, Heimberger AB.
Immune Microenvironment Landscape in CNS Tumors and Role in Responses to Immunotherapy.
Cells. 2021 Aug 9;10(8):2032. doi: 10.3390/cells10082032. PMID: 34440802. Review.

Xiao F, Shen J, Zhang L, Yang J, Weng Y, Fang Z, Zhang C, Ye H, Zhan R, Zheng X.
Unilateral Subfrontal Approach for Giant Tuberculum Sellae Meningioma: Single Center Experience and Review of the Literature.
Front Oncol. 2021 Aug 9;11:708235. doi: 10.3389/fonc.2021.708235. PMID: 34434897. Case series & Review.

Siroya HL, Bhagavatula ID, Bhat DI, Sadashiva N.
Intracranial high-grade glioma with malignant progression of spinal intramedullary metastasis: an atypical presentation with review of literature.
Br J Neurosurg. 2021 Aug 16:1-7. doi: 10.1080/02688697.2021.1961682. Online ahead of print. PMID: 34396889. Case report & Review;

Chen M, Medarova Z, Moore A.
Role of microRNAs in glioblastoma.
Oncotarget. 2021 Aug 17;12(17):1707-1723. doi: 10.18632/oncotarget.28039. PMID: 34434499. Review.

Leong YQ, Lee SWH, Ng KY.
Cancer risk in Parkinson disease: An updated systematic review and meta-analysis.
Eur J Neurol. 2021 Aug 17. doi: 10.1111/ene.15069. Online ahead of print. PMID: 34403556. Review & Meta-analysis;

Aryal M, Porter T.
Emerging Therapeutic Strategies for Brain Tumors.
Neuromolecular Med. 2021 Aug 18. doi: 10.1007/s12017-021-08681-z. Online ahead of print. PMID: 34406634. Review;

Guven DC, Aksun MS, Cakir IY, Kilickap S, Kertmen N.
The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme.
Future Oncol. 2021 Aug 19. doi: 10.2217/fon-2021-0681. Online ahead of print. PMID: 34409854. Meta-analysis;

Leroy HA, Guérin L, Lecomte F, Baert G, Vignion AS, Mordon S, Reyns N.
Is interstitial photodynamic therapy for brain tumors ready for clinical practice? A systematic review.
Photodiagnosis Photodyn Ther. 2021 Aug 19;36:102492. doi: 10.1016/j.pdpdt.2021.102492. Online ahead of print. PMID: 34419674. Review;

Tomar MS, Kumar A, Srivastava C, Shrivastava A.
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Biochim Biophys Acta Rev Cancer. 2021 Aug 20;1876(2):188616. doi: 10.1016/j.bbcan.2021.188616. Online ahead of print. PMID: 34419533. Review;

Gatto L, Franceschi E, Tosoni A, Di Nunno V, Maggio I, Tonon C, Lodi R, Agati R, Bartolini S, Brandes AA.
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review.
Clin Case Rep. 2021 Aug 21;9(8):e04604. doi: 10.1002/ccr3.4604. PMID: 34457284. Case report & Review.

Tsakatikas S, Papageorgiou G, Fioretzaki R, Kosmas C.
An overview of current results with the vincristine-irinotecan-temozolomide combination with or without bevacizumab in pediatric, adolescence and adult solid tumors.
Crit Rev Oncol Hematol. 2021 Aug 21;166:103457. doi: 10.1016/j.critrevonc.2021.103457. Online ahead of print. PMID: 34428555. Review;

Basheer AS, Abas F, Othman I, Naidu R.
Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications.
Cancers (Basel). 2021 Aug 23;13(16):4226. doi: 10.3390/cancers13164226. PMID: 34439380. Review.

Bruschi M, Grill J, Guerrini-Rousseau L.
Pediatric brain tumors as a developmental disease.
Curr Opin Oncol. 2021 Aug 23. doi: 10.1097/CCO.0000000000000782. Online ahead of print. PMID: 34431811. Review;

Miller KD, Ostrom QT, Kruchko C, Patil N, Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL, Barnholtz-Sloan JS.
Brain and other central nervous system tumor statistics, 2021.
CA Cancer J Clin. 2021 Sep;71(5):381-406. doi: 10.3322/caac.21693. Online 2021 Aug 24. PMID: 34427324. Review.

González L, Castro S, Villa E, Zomosa G.
Surgical resection versus stereotactic radiosurgery on local recurrence and survival for patients with a single brain metastasis: a systematic review and meta-analysis.
Br J Neurosurg. 2021 Aug 25:1-11. doi: 10.1080/02688697.2021.1950623. Online ahead of print. PMID: 34431733. Review & Meta-analysis;

Turkez H, Tozlu OO, Arslan ME, Mardinoglu A.
Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies.
Neurochem Int. 2021 Aug 25;150:105168. doi: 10.1016/j.neuint.2021.105168. Online ahead of print. PMID: 34450218. Review;

Geurts M, Snijders TJ, van den Bent MJ.
Treatment of anaplastic gliomas: evidences and controversies.
Curr Opin Oncol. 2021 Aug 26. doi: 10.1097/CCO.0000000000000785. Online ahead of print. PMID: 34456249. Review;

Maggio I, Franceschi E, Gatto L, Tosoni A, Di Nunno V, Tonon C, Brandes AA.
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.
Expert Rev Anticancer Ther. 2021 Aug 26:1-8
. doi: 10.1080/14737140.2021.1971518. Online ahead of print. PMID: 34433354. Review;

Bastiancich C, Malfanti A, Préat V, Rahman R.
Rationally designed drug delivery systems for the local treatment of resected glioblastoma.
Adv Drug Deliv Rev. 2021 Aug 27;177:113951. doi: 10.1016/j.addr.2021.113951. Online ahead of print. PMID: 34461201. Review;